COVID-19 pandemic in the Andaman and Nicobar Islands

[1] The islands have pursued a strategy of zero COVID-19 transmission, which, except for three flareups in August 2020, May 2021, and January 2022, which were swiftly contained, have resulted in no community outbreaks.

[2] In 2021 during the 2nd Wave of COVID-19 Pandemic the Colleges & educational Institutions of Andaman & Nicobar Islands was still continued follow the offline mode of teaching.

On 24 April 2021 an order was passed from secretariat to close all the college with immediate effect and continue all academic activities in online mode.

[10] On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.

[13] On 21 February 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.